Arie Perry, MD - Publications

Pathology and Laboratory Medicine University of California, San Francisco, San Francisco, CA 

87 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Han SJ, Reis G, Kohanbash G, Shrivastav S, Magill ST, Molinaro AM, McDermott MW, Theodosopoulos PV, Aghi MK, Berger MS, Butowski NA, Barani I, Phillips JJ, Perry A, Okada H. Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma. Journal of Neuro-Oncology. PMID 27624915 DOI: 10.1007/s11060-016-2256-0  0.92
2016 Phillips JJ, Gong H, Chen K, Joseph NM, van Ziffle J, Jin LW, Bastian BC, Bollen AW, Perry A, Nicolaides T, Solomon DA, Shieh JT. Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation. Acta Neuropathologica. PMID 27624885 DOI: 10.1007/s00401-016-1616-3  0.92
2016 Ferris SP, Goode B, Joseph NM, Kline CN, Samuel D, Gupta N, Bollen A, Perry A, Mueller S, Solomon DA. IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age. Acta Neuropathologica. PMID 27161253 DOI: 10.1007/s00401-016-1579-4  0.92
2016 Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica. 131: 803-20. PMID 27157931 DOI: 10.1007/s00401-016-1545-1  0.92
2016 Hasselblatt M, Thomas C, Hovestadt V, Schrimpf D, Johann P, Bens S, Oyen F, Peetz-Dienhart S, Crede Y, Wefers A, Vogel H, Riemenschneider MJ, Antonelli M, Giangaspero F, Bernardo MC, ... ... Perry A, et al. Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis. Acta Neuropathologica. PMID 27067307 DOI: 10.1007/s00401-016-1574-9  0.92
2016 Schwetye KE, Joseph NM, Al-Kateb H, Rich KM, Schmidt RE, Perry A, Gutmann DH, Dahiya S. Gliosarcomas lack BRAF(V600E) mutation, but a subset exhibit β-catenin nuclear localization. Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 26932501 DOI: 10.1111/neup.12293  0.92
2016 Röhrich M, Koelsche C, Schrimpf D, Capper D, Sahm F, Kratz A, Reuss J, Hovestadt V, Jones DT, Bewerunge-Hudler M, Becker A, Weis J, Mawrin C, Mittelbronn M, Perry A, et al. Methylation-based classification of benign and malignant peripheral nerve sheath tumors. Acta Neuropathologica. PMID 26857854 DOI: 10.1007/s00401-016-1540-6  0.92
2016 Vaubel RA, Chen SG, Raleigh DR, Link MJ, Chicoine MR, Barani I, Jenkins SM, Aleff PA, Rodriguez FJ, Burger PC, Dahiya S, Perry A, Giannini C. Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature. Journal of Neuropathology and Experimental Neurology. 75: 44-52. PMID 26705409 DOI: 10.1093/jnen/nlv006  0.92
2015 Solomon DA, Wood MD, Tihan T, Bollen AW, Gupta N, Phillips JJ, Perry A. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations. Brain Pathology (Zurich, Switzerland). PMID 26517431 DOI: 10.1111/bpa.12336  0.92
2015 Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W, Jenrette J, Barani I, Shrieve D, Sloan A, Bovi J, Kwok Y, Burri SH, Chao ST, Spalding AC, et al. Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro-Oncology. PMID 26493095 DOI: 10.1093/neuonc/nov247  0.92
2015 Butowski N, Colman H, De Groot JF, Omuro AM, Nayak L, Wen PY, Cloughesy TF, Marimuthu A, Haidar S, Perry A, Huse J, Phillips J, West BL, Nolop KB, Hsu HH, et al. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neuro-Oncology. PMID 26449250 DOI: 10.1093/neuonc/nov245  0.92
2015 Alexandrescu S, Korshunov A, Lai SH, Dabiri S, Patil S, Li R, Shih CS, Bonnin JM, Baker JA, Du E, Scharnhorst DW, Samuel D, Ellison DW, Perry A. Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas - Same Entity or First Cousins? Brain Pathology (Zurich, Switzerland). PMID 26238627 DOI: 10.1111/bpa.12295  0.92
2015 Nauen D, Haley L, Lin MT, Perry A, Giannini C, Burger PC, Rodriguez FJ. Molecular Analysis of Pediatric Oligodendrogliomas Highlights Genetic Differences with Adult Counterparts and Other Pediatric Gliomas. Brain Pathology (Zurich, Switzerland). PMID 26206478 DOI: 10.1111/bpa.12291  0.92
2015 Menke JR, Raleigh DR, Gown AM, Thomas S, Perry A, Tihan T. Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Acta Neuropathologica. 130: 441-3. PMID 26195322 DOI: 10.1007/s00401-015-1459-3  0.92
2015 Cimino PJ, Gonzalez-Cuyar LF, Perry A, Dahiya S. Lack of BRAF-V600E Mutation in Papillary Tumor of the Pineal Region. Neurosurgery. 77: 621-8. PMID 26125673 DOI: 10.1227/NEU.0000000000000877  0.92
2015 Liverman C, Mafra M, Chuang SS, Shivane A, Chakrabarty A, Highley R, Hilton DA, Byrne NP, Wesseling P, Perry A. A clinicopathologic study of 11 rosette-forming meningiomas: a rare and potentially confusing pattern. Acta Neuropathologica. PMID 26106026 DOI: 10.1007/s00401-015-1456-6  0.92
2015 Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, ... ... Perry A, et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. The New England Journal of Medicine. 372: 2499-508. PMID 26061753 DOI: 10.1056/NEJMoa1407279  0.92
2015 Wesseling P, van den Bent M, Perry A. Oligodendroglioma: pathology, molecular mechanisms and markers. Acta Neuropathologica. 129: 809-27. PMID 25943885 DOI: 10.1007/s00401-015-1424-1  0.92
2015 Hirbe AC, Dahiya S, Miller CA, Li T, Fulton RS, Zhang X, McDonald S, DeSchryver K, Duncavage EJ, Walrath J, Reilly KM, Abel HJ, Pekmezci M, Perry A, Ley TJ, et al. Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 25925892 DOI: 10.1158/1078-0432.CCR-14-3049  0.92
2015 Hansen JM, Larsen VA, Scheie D, Perry A, Skjøth-Rasmussen J. Primary intracranial angiomatoid fibrous histiocytoma presenting with anaemia and migraine-like headaches and aura as early clinical features. Cephalalgia : An International Journal of Headache. PMID 25900984 DOI: 10.1177/0333102415583988  0.92
2015 Reis GF, Pekmezci M, Hansen HM, Rice T, Marshall RE, Molinaro AM, Phillips JJ, Vogel H, Wiencke JK, Wrensch MR, Walsh KM, Perry A. CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas. Journal of Neuropathology and Experimental Neurology. 74: 442-52. PMID 25853694 DOI: 10.1097/NEN.0000000000000188  0.92
2015 Pekmezci M, Perry A. Practical molecular pathologic diagnosis of infiltrating gliomas. Surgical Pathology Clinics. 8: 49-61. PMID 25783821 DOI: 10.1016/j.path.2014.10.004  0.92
2015 Korshunov A, Ryzhova M, Hovestadt V, Bender S, Sturm D, Capper D, Meyer J, Schrimpf D, Kool M, Northcott PA, Zheludkova O, Milde T, Witt O, Kulozik AE, Reifenberger G, ... ... Perry A, et al. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathologica. 129: 669-78. PMID 25752754 DOI: 10.1007/s00401-015-1405-4  0.92
2015 Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A. High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathologica. 129: 609-10. PMID 25720745 DOI: 10.1007/s00401-015-1400-9  0.92
2015 Okimoto RA, Perry A, Rubenstein JL. 77-year-old woman with a dural-based mass. Marginal zone B-cell lymphoma (MZBCL). Brain Pathology (Zurich, Switzerland). 25: 111-2. PMID 25521182 DOI: 10.1111/bpa.12233  0.92
2015 Ud Din N, Pekmezci M, Javed G, Horvai AE, Ahmad Z, Faheem M, Navarro AL, López-Terrada D, Perry A. Low-grade small round cell tumor of the cauda equina with EWSR1-WT1 fusion and indolent clinical course. Human Pathology. 46: 153-8. PMID 25454478 DOI: 10.1016/j.humpath.2014.09.015  0.92
2015 Alexandrescu S, Orengo JP, Toossi S, Perry A, Treseler P, Hess C, Margeta M. CNS intravascular large cell lymphoma in a patient with autoimmune hemolytic anemia. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 35: 170-4. PMID 25378202 DOI: 10.1111/neup.12175  0.92
2015 Chavez JA, Din NU, Memon WA, Perry A. Spinal non-melanotic schwannoma with extensive calcifications. Clinical Neuropathology. 34: 47-49. PMID 25207621 DOI: 10.5414/NP300781  0.92
2015 Pekmezci M, Reuss DE, Hirbe AC, Dahiya S, Gutmann DH, von Deimling A, Horvai AE, Perry A. Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 187-200. PMID 25189642 DOI: 10.1038/modpathol.2014.109  0.92
2015 Ghoshal N, Perry A, McKeel D, Schmidt RE, Carter D, Norton J, Zou WQ, Xiao X, Puoti G, Notari S, Gambetti P, Morris JC, Cairns NJ. Variably Protease-sensitive Prionopathy in an Apparent Cognitively Normal 93-Year-Old. Alzheimer Disease and Associated Disorders. 29: 173-6. PMID 24845762 DOI: 10.1097/WAD.0000000000000049  0.92
2014 Hainfellner J, Louis DN, Perry A, Wesseling P. Letter in response to David N. Louis et al, International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading, Brain Pathology, doi: 10.1111/bpa.12171. Brain Pathology (Zurich, Switzerland). 24: 671-2. PMID 25345897 DOI: 10.1111/bpa.12187  0.92
2014 Reis GF, Perry A. A 67-year-old man with a lumbar spine lesion. Brain Pathology (Zurich, Switzerland). 24: 547-8. PMID 25323670 DOI: 10.1111/bpa.12201  0.92
2014 Venneti S, Santi M, Felicella MM, Yarilin D, Phillips JJ, Sullivan LM, Martinez D, Perry A, Lewis PW, Thompson CB, Judkins AR. A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas. Acta Neuropathologica. 128: 743-53. PMID 25200322 DOI: 10.1007/s00401-014-1338-3  0.92
2014 Yu JP, Wilson DM, Chang EF, Cotter J, Perry A, Mahindra A, Glastonbury CM. Isolated intracerebral light chain deposition disease: novel imaging and pathologic findings. Clinical Imaging. 38: 868-71. PMID 25084689 DOI: 10.1016/j.clinimag.2014.06.015  0.92
2014 Chavez JA, Din NU, Memon A, Perry A. Anaplastic chordoma with loss of INI1 and brachyury expression in a 2-year-old girl. Clinical Neuropathology. 33: 418-420. PMID 25074874 DOI: 10.5414/NP300724  0.92
2014 Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, et al. International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathology (Zurich, Switzerland). 24: 429-35. PMID 24990071 DOI: 10.1111/bpa.12171  0.92
2014 Ali S, Joseph NM, Perry A, Barajas RF, Cha S. Apparent diffusion coefficient in glioblastoma with PNET-like components, a GBM variant. Journal of Neuro-Oncology. 119: 353-60. PMID 24893732 DOI: 10.1007/s11060-014-1485-3  0.92
2014 Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M, Kim SK, Ra YS, Nakamura H, Fangusaro J, Hwang E, Kiehna E, Toledano H, Wang Y, Shi Q, ... ... Perry A, et al. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathologica. 128: 291-303. PMID 24839957 DOI: 10.1007/s00401-014-1291-1  0.92
2014 de Kock L, Sabbaghian N, Plourde F, Srivastava A, Weber E, Bouron-Dal Soglio D, Hamel N, Choi JH, Park SH, Deal CL, Kelsey MM, Dishop MK, Esbenshade A, Kuttesch JF, Jacques TS, ... Perry A, et al. Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathologica. 128: 111-22. PMID 24839956 DOI: 10.1007/s00401-014-1285-z  0.92
2014 Perry A. A blustery wind of change. Brain Pathology (Zurich, Switzerland). 24: i-ii. PMID 24720898 DOI: 10.1111/bpa.12143  0.92
2014 Kool M, Jones DT, Jäger N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, ... ... Perry A, et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell. 25: 393-405. PMID 24651015 DOI: 10.1016/j.ccr.2014.02.004  0.92
2014 Clarke JL, Molinaro AM, Phillips JJ, Butowski NA, Chang SM, Perry A, Costello JF, DeSilva AA, Rabbitt JE, Prados MD. A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma. Neuro-Oncology. 16: 984-90. PMID 24637230 DOI: 10.1093/neuonc/nou029  0.92
2014 Sabha N, Knobbe CB, Maganti M, Al Omar S, Bernstein M, Cairns R, Çako B, von Deimling A, Capper D, Mak TW, Kiehl TR, Carvalho P, Garrett E, Perry A, Zadeh G, et al. Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas. Neuro-Oncology. 16: 914-23. PMID 24470545 DOI: 10.1093/neuonc/not299  0.92
2014 Lal A, Dahiya S, Gonzales M, Hiniker A, Prayson R, Kleinschmidt-DeMasters BK, Perry A. IgG4 overexpression is rare in meningiomas with a prominent inflammatory component: a review of 16 cases. Brain Pathology (Zurich, Switzerland). 24: 352-9. PMID 24467316 DOI: 10.1111/bpa.12128  0.92
2014 Hirbe AC, Pekmezci M, Dahiya S, Apicelli AJ, Van Tine BA, Perry A, Gutmann DH. BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Neuro-Oncology. 16: 466-7. PMID 24366910 DOI: 10.1093/neuonc/not248  0.92
2014 Korshunov A, Sturm D, Ryzhova M, Hovestadt V, Gessi M, Jones DT, Remke M, Northcott P, Perry A, Picard D, Rosenblum M, Antonelli M, Aronica E, Schüller U, Hasselblatt M, et al. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathologica. 128: 279-89. PMID 24337497 DOI: 10.1007/s00401-013-1228-0  0.92
2014 Krishnan C, Vogel H, Perry A. Atypical teratoid/rhabdoid tumor with ganglioglioma-like differentiation: case report and review of the literature. Human Pathology. 45: 185-8. PMID 24034858 DOI: 10.1016/j.humpath.2013.07.039  0.92
2013 Cykowski MD, Allen RA, Kanaly AC, Fung KM, Marshall R, Perry A, Stolzenberg ED, Dunn ST. The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features. Journal of Neuro-Oncology. 115: 477-86. PMID 24057326 DOI: 10.1007/s11060-013-1249-5  0.92
2013 Perry A. Practicing neuropathology under great adversity. Brain Pathology (Zurich, Switzerland). 23: i. PMID 23773606 DOI: 10.1111/bpa.12065  0.92
2013 Abedalthagafi M, Phillips JJ, Kim GE, Mueller S, Haas-Kogen DA, Marshall RE, Croul SE, Santi MR, Cheng J, Zhou S, Sullivan LM, Martinez-Lage M, Judkins AR, Perry A. The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 1425-32. PMID 23765250 DOI: 10.1038/modpathol.2013.90  0.92
2013 Reis GF, Bloomer MM, Perry A, Phillips JJ, Grenert JP, Karnezis AN, Tihan T. Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 1279-87. PMID 23702730 DOI: 10.1038/modpathol.2013.79  0.92
2013 Venneti S, Felicella MM, Coyne T, Phillips JJ, Gorovets D, Huse JT, Kofler J, Lu C, Tihan T, Sullivan LM, Santi M, Judkins AR, Perry A, Thompson CB. Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas. Journal of Neuropathology and Experimental Neurology. 72: 298-306. PMID 23481705 DOI: 10.1097/NEN.0b013e3182898113  0.92
2013 Phillips JJ, Aranda D, Ellison DW, Judkins AR, Croul SE, Brat DJ, Ligon KL, Horbinski C, Venneti S, Zadeh G, Santi M, Zhou S, Appin CL, Sioletic S, Sullivan LM, ... ... Perry A, et al. PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma. Brain Pathology (Zurich, Switzerland). 23: 565-73. PMID 23438035 DOI: 10.1111/bpa.12043  0.92
2013 Perry A. Gratitude for a job well done! Brain Pathology (Zurich, Switzerland). 23: i. PMID 23432653 DOI: 10.1111/bpa.12036  0.92
2013 Jiang T, Perry A, Dacey RG, Zipfel GJ, Derdeyn CP. Intracranial atherosclerotic disease associated with moyamoya collateral formation: histopathological findings. Journal of Neurosurgery. 118: 1030-4. PMID 23394336 DOI: 10.3171/2013.1.JNS12565  0.92
2013 Jahangiri A, De Lay M, Miller LM, Carbonell WS, Hu YL, Lu K, Tom MW, Paquette J, Tokuyasu TA, Tsao S, Marshall R, Perry A, Bjorgan KM, Chaumeil MM, Ronen SM, et al. Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1773-83. PMID 23307858 DOI: 10.1158/1078-0432.CCR-12-1281  0.92
2013 Motomura K, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nakazato Y, Tanaka Y, Nonoguchi N, Pierscianek D, Kim YH, Mariani L, Vital A, Perry A, et al. PDGFRA gain in low-grade diffuse gliomas. Journal of Neuropathology and Experimental Neurology. 72: 61-6. PMID 23242283 DOI: 10.1097/NEN.0b013e31827c4b5b  0.92
2013 Aref D, Moffatt CJ, Agnihotri S, Ramaswamy V, Dubuc AM, Northcott PA, Taylor MD, Perry A, Olson JM, Eberhart CG, Croul SE. Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development. Brain Pathology (Zurich, Switzerland). 23: 178-91. PMID 22966790 DOI: 10.1111/j.1750-3639.2012.00631.x  0.92
2012 Korshunov A, Ryzhova M, Jones DT, Northcott PA, van Sluis P, Volckmann R, Koster J, Versteeg R, Cowdrey C, Perry A, Picard D, Rosenblum M, Giangaspero F, Aronica E, Schüller U, et al. LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathologica. 124: 875-81. PMID 23161096 DOI: 10.1007/s00401-012-1068-3  0.92
2012 Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D, Mosier S, Lin MT, Eberhart CG, Burger PC. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathologica. 124: 627-41. PMID 22941225 DOI: 10.1007/s00401-012-1037-x  0.92
2012 Lusis EA, Scheithauer BW, Yachnis AT, Fischer BR, Chicoine MR, Paulus W, Perry A. Meningiomas in pregnancy: a clinicopathologic study of 17 cases. Neurosurgery. 71: 951-61. PMID 22843130 DOI: 10.1227/NEU.0b013e31826adf65  0.92
2012 Ellezam B, Theeler BJ, Walbert T, Mammoser AG, Horbinski C, Kleinschmidt-DeMasters BK, Perry A, Puduvalli V, Fuller GN, Bruner JM, Aldape KD. Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas. Acta Neuropathologica. 124: 449-51. PMID 22772980 DOI: 10.1007/s00401-012-1011-7  0.92
2012 Felicella MM, Hagenkord JM, Kash SF, Powers MP, Berger MS, Perry A. A common 8q (MYC) amplification detected in a multifocal anaplastic astrocytoma by SNP array karyotyping. Clinical Neuropathology. 31: 210-5. PMID 22720694 DOI: 10.5414/NP300484  0.92
2012 Swartling FJ, Savov V, Persson AI, Chen J, Hackett CS, Northcott PA, Grimmer MR, Lau J, Chesler L, Perry A, Phillips JJ, Taylor MD, Weiss WA. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC. Cancer Cell. 21: 601-13. PMID 22624711 DOI: 10.1016/j.ccr.2012.04.012  0.92
2012 Huillard E, Hashizume R, Phillips JJ, Griveau A, Ihrie RA, Aoki Y, Nicolaides T, Perry A, Waldman T, McMahon M, Weiss WA, Petritsch C, James CD, Rowitch DH. Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy. Proceedings of the National Academy of Sciences of the United States of America. 109: 8710-5. PMID 22586120 DOI: 10.1073/pnas.1117255109  0.92
2012 Bien-Willner GA, López-Terrada D, Bhattacharjee MB, Patel KU, Stankiewicz P, Lupski JR, Pfeifer JD, Perry A. Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement. Neuro-Oncology. 14: 831-40. PMID 22573308 DOI: 10.1093/neuonc/nos086  0.92
2012 Kim YH, Nonoguchi N, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Mariani L, Giangaspero F, Tanaka Y, Nakazato Y, Vital A, Mittelbronn M, Perry A, Ohgaki H. Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss. Brain Pathology (Zurich, Switzerland). 22: 834-40. PMID 22568401 DOI: 10.1111/j.1750-3639.2012.00601.x  0.92
2012 Goldhoff P, Clarke J, Smirnov I, Berger MS, Prados MD, James CD, Perry A, Phillips JJ. Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype. Journal of Neuropathology and Experimental Neurology. 71: 83-9. PMID 22157621 DOI: 10.1097/NEN.0b013e31823fe8f1  0.92
2012 Creach KM, Rubin JB, Leonard JR, Limbrick DD, Smyth MD, Dacey R, Rich KM, Dowling JL, Grubb RL, Linette GP, King AA, Michalski JM, Park TS, Perry A, Simpson JR, et al. Oligodendrogliomas in children. Journal of Neuro-Oncology. 106: 377-82. PMID 21842314 DOI: 10.1007/s11060-011-0674-6  0.92
2011 Perry A. Experiencing Japanese utopia. Brain Pathology (Zurich, Switzerland). 21: i. PMID 21995965 DOI: 10.1111/j.1750-3639.2011.00534.x  0.92
2011 Deshmukh H, Yu J, Shaik J, MacDonald TJ, Perry A, Payton JE, Gutmann DH, Watson MA, Nagarajan R. Identification of transcriptional regulatory networks specific to pilocytic astrocytoma. Bmc Medical Genomics. 4: 57. PMID 21745356 DOI: 10.1186/1755-8794-4-57  0.92
2011 Perry A. Formula for success =3A + 4C + F. Brain Pathology (Zurich, Switzerland). 21: iii-iv. PMID 21668553 DOI: 10.1111/j.1750-3639.2011.00498.x  0.92
2011 Remke M, Hielscher T, Northcott PA, Witt H, Ryzhova M, Wittmann A, Benner A, von Deimling A, Scheurlen W, Perry A, Croul S, Kulozik AE, Lichter P, Taylor MD, Pfister SM, et al. Adult medulloblastoma comprises three major molecular variants. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2717-23. PMID 21632505 DOI: 10.1200/JCO.2011.34.9373  0.92
2011 Patil S, Scheithauer BW, Strom RG, Mafra M, Chicoine MR, Perry A. Malignant meningiomas with epithelial (adenocarcinoma-like) metaplasia: a study of 3 cases. Neurosurgery. 69: 884-92. PMID 21558975 DOI: 10.1227/NEU.0b013e318222dc6f  0.92
2011 Clifford DB, Ances B, Costello C, Rosen-Schmidt S, Andersson M, Parks D, Perry A, Yerra R, Schmidt R, Alvarez E, Tyler KL. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Archives of Neurology. 68: 1156-64. PMID 21555606 DOI: 10.1001/archneurol.2011.103  0.92
2011 Yu J, Deshmukh H, Payton JE, Dunham C, Scheithauer BW, Tihan T, Prayson RA, Guha A, Bridge JA, Ferner RE, Lindberg GM, Gutmann RJ, Emnett RJ, Salavaggione L, Gutmann DH, ... ... Perry A, et al. Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1924-34. PMID 21325289 DOI: 10.1158/1078-0432.CCR-10-1551  0.92
2011 Horbinski C, Kofler J, Yeaney G, Camelo-Piragua S, Venneti S, Louis DN, Perry A, Murdoch G, Nikiforova M. Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas. Brain Pathology (Zurich, Switzerland). 21: 564-74. PMID 21314850 DOI: 10.1111/j.1750-3639.2011.00480.x  0.92
2011 Perry A. Does there always need to be brain pathology in brain pathology? Brain Pathology (Zurich, Switzerland). 21: i. PMID 21269336 DOI: 10.1111/j.1750-3639.2010.00470.x  0.92
2011 Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, Kenney AM, Brat DJ, Perry A, Yong WH, Taylor RE, Bailey S, Clifford SC, Gilbertson RJ. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathologica. 121: 381-96. PMID 21267586 DOI: 10.1007/s00401-011-0800-8  0.92
2011 Horbinski C, Miller CR, Perry A. Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade. Brain Pathology (Zurich, Switzerland). 21: 57-73. PMID 21129060 DOI: 10.1111/j.1750-3639.2010.00453.x  0.92
2011 Perry A. Molecular diagnostics in neuro-oncology. Introduction. Brain Pathology (Zurich, Switzerland). 21: 55-6. PMID 21129059 DOI: 10.1111/j.1750-3639.2010.00452.x  0.92
2010 Chan OT, Chen ZM, Chung F, Kawachi K, Phan DC, Himmelfarb E, Lin F, Perry A, Wang HL. Lack of HER2 overexpression and amplification in small intestinal adenocarcinoma. American Journal of Clinical Pathology. 134: 880-5. PMID 21088150 DOI: 10.1309/AJCPK6QHNNOEMJIM  0.92
2010 Dorward IG, Luo J, Perry A, Gutmann DH, Mansur DB, Rubin JB, Leonard JR. Postoperative imaging surveillance in pediatric pilocytic astrocytomas. Journal of Neurosurgery. Pediatrics. 6: 346-52. PMID 20887107 DOI: 10.3171/2010.7.PEDS10129  0.92
2009 Perry A, Miller CR, Gujrati M, Scheithauer BW, Zambrano SC, Jost SC, Raghavan R, Qian J, Cochran EJ, Huse JT, Holland EC, Burger PC, Rosenblum MK. Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases. Brain Pathology (Zurich, Switzerland). 19: 81-90. PMID 18452568 DOI: 10.1111/j.1750-3639.2008.00167.x  0.92
2008 Trembath D, Miller CR, Perry A. Gray zones in brain tumor classification: evolving concepts. Advances in Anatomic Pathology. 15: 287-97. PMID 18724102 DOI: 10.1097/PAP.0b013e3181836a03  0.92
2007 Miller CR, Perry A. Glioblastoma. Archives of Pathology & Laboratory Medicine. 131: 397-406. PMID 17516742 DOI: 10.1043/1543-2165(2007)131[397:G]2.0.CO;2  0.92
2006 Miller CR, Dunham CP, Scheithauer BW, Perry A. Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 5419-26. PMID 17135643 DOI: 10.1200/JCO.2006.08.1497  0.92
Show low-probability matches.